Abhay H. Pande

Mohali, PB 160062, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy.

Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy.

Journal: Applied biochemistry and biotechnology

Published: April 09, 2026

The rise of bispecific T-cell engager (BsTCE) antibodies: a potentially game-changing approach for breast cancer therapy?

The rise of bispecific T-cell engager (BsTCE) antibodies: a potentially game-changing approach for breast cancer therapy?

Journal: Drug discovery today

Published: January 19, 2026

Correction: Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics.

Correction: Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics.

Journal: Pharmaceutical research

Published: January 08, 2026

Development and partial characterization of fused human endostatin.

Development and partial characterization of fused human endostatin.

Journal: Protein expression and purification

Published: December 31, 2025

Radioligand-Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis.

Radioligand-Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis.

Journal: Molecular diagnosis & therapy

Published: August 25, 2025

Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions.

Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions.

Journal: Current oncology reports

Published: July 23, 2025

Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics.

Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics.

Journal: Pharmaceutical research

Published: July 09, 2025

Challenges and advances in the development of antidotes against A-series nerve agents.

Challenges and advances in the development of antidotes against A-series nerve agents.

Journal: Archives of toxicology

Published: June 24, 2025

Efficacy and safety of transcutaneous electrical nerve stimulation versus oxybutynin in the treatment of overactive bladder in children: a systematic review and meta-analysis.

Efficacy and safety of transcutaneous electrical nerve stimulation versus oxybutynin in the treatment of overactive bladder in children: a systematic review and meta-analysis.

Journal: International urology and nephrology

Published: June 23, 2025

Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations.

Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations.

Journal: Future oncology (London, England)

Published: May 19, 2025

PolyBodies for the Treatment of Respiratory Syncytial Virus Infection.

PolyBodies for the Treatment of Respiratory Syncytial Virus Infection.

Journal: Drug discovery today

Published: May 16, 2025

Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study.

Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study.

Journal: ACS pharmacology & translational science

Published: December 30, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026